Stoyanova Lab News
Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay
Exiting new study from our lab suggest that CASP8 may serve as a biomarker for high-risk prostate cancer and potentially renal cancer. Congratulations Laura and team.
New review article on the role of Trop2 in prostate cancer
Stoyanova Lab publishes a review article discussing the role of Trop2 in prostate cancer. Congratulations Michelle!
Developing new imaging approach for methionine aminopeptidase II for prostate cancer risk stratification
Exciting new results from our lab collaborative work reveal a new imaging approach for risk stratification of prostate cancer.
Dr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant
Dr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant
“An automated disposable tool for liquid biopsy-based detection of exosomal biomarkers for early cancer detection”
Discovery of ferroptosis inducers as a new therapeutic strategy for advanced prostate cancer
New study from our lab demonstrates that ferroptosis inducers represent a new therapeutic approach for advanced prostate cancer.
Identification of a new serum biomarker for clinically significant prostate cancer
Exciting new results from our lab collaborative work reveal PTN as a new serum biomarker of pro-metastatic prostate cancer. Congratulations Shiqin and all collaborators!
Identification of a new important regulator of prostate cancer growth and metastasis
New study from our lab demonstrates plectin is an important regulator of prostate cancer growth and metastatic colonization. Congratulations Mark, Meghan and team.
Tanya Stoyanova receives 2020 Society of Basic Urologic Research Young Investigator Award from the Society of Basic Urologic Research
Congratulations Tanya!
En-chi Hsu receives Travel Award from the Society of Basic Urologic Research
Congratulations En-chi!
